BRIEF-Vanda Pharmaceuticals qtrly loss per share $0.01
November 02, 2016 at 16:13 PM EDT
* FY2016 earnings per share view $-0.50, revenue view $147.0 million -- Thomson Reuters I/B/E/S
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.